www.tcm-mec.gc.ca/1994_pr_Nov_08-en.aspFairchild Investment Inc., Vancouver, British Columbia
Fairchild Investment has reached an agreement with Beijing Stone Group Co. to acquire control of Stone Pharmaceutical, located in the Province of Anhui. Stone Pharmaceutical manufactures Vitamin C and other related pharmaceutical products, with the majority of its production currently being sold in the United States. Stone and Fairchild are committed to invest approximately $30 million for the expansion of Stone Pharmaceutical's production facilities. Stone and Fairchild will also work together to seek out investment opportunities in the pharmaceutical industry, in China and Canada. They intend to establish a facility in Canada for the manufacture of pharmaceutical products to be sold in North America.
https://www.tcm-mec.gc.ca/1994_pr_Nov_08-en.asp